Anti-KIF5B+KIF5C antibody [EPR10276(B)]
- RabMAb
- Recombinant
- KO Validated
- 20ul selling size
- What is this?
4
(3 Reviews)
|
(54 Publications)
Rabbit Recombinant Monoclonal KIF5B antibody. Suitable for IHC-P, IP, WB, ICC/IF, Flow Cyt (Intra) and reacts with Human, Mouse, Rat, Recombinant fragment - Mouse samples. Cited in 54 publications.
View Alternative Names
KNS, KNS1, KIF5B, Kinesin-1 heavy chain, Conventional kinesin heavy chain, Ubiquitous kinesin heavy chain, UKHC, KIAA0531, NKHC2, KIF5C, Kinesin heavy chain isoform 5C, Kinesin heavy chain neuron-specific 2, Kinesin-1
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-KIF5B+KIF5C antibody [EPR10276(B)] (AB167429)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human breast carcinoma tissue sections labeling KIF5B with Purified ab167429 at 1 : 250 dilution (0.07 μg/ml). Heat mediated antigen retrieval was performed using ab93684 (Tris/EDTA buffer, pH 9.0). Tissue was counterstained with Hematoxylin. ImmunoHistoProbe one step HRP Polymer (ready to use) secondary antibody was used at 1 : 0 dilution. PBS instead of the primary antibody was used as the negative control.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-KIF5B+KIF5C antibody [EPR10276(B)] (AB167429)
Intracellular Flow Cytometry analysis of HepG2 (Human hepatocellular carcinoma epithelial cell) cells labeling KIF5B with purified ab167429 at 1/20 dilution (10μg/ml) (red). Cells were fixed with 4% Paraformaldehyde and permeabilised with 90% methanol. A Goat anti rabbit IgG (Alexa Fluor® 488) secondary antibody was used at 1/2000 dilution. Isotype control - Rabbit monoclonal IgG (Black). Unlabeled control - Cell without incubation with primary antibody and secondary antibody (Blue).
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-KIF5B+KIF5C antibody [EPR10276(B)] (AB167429)
Immunofluorescence analysis of HeLa cells, labeling KIF5B using unpurified ab167429 at a 1/100 dilution.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-KIF5B+KIF5C antibody [EPR10276(B)] (AB167429)
Immunohistochemical analysis of formalin-fixed, paraffin-embedded Human brain tissue, labeling KIF5B using unpurified ab167429 at a 1/100 dilution.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-KIF5B+KIF5C antibody [EPR10276(B)] (AB167429)
Immunocytochemistry/Immunofluorescence analysis HepG2(human hepatocellular carcinoma) labelling KIF5B with purified ab167429 at 1/500. Cells were fixed with 4% PFA and permeabilized with 0.1% Triton X-100. An Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/1000) was used as the secondary antibody (ab150077). Nuclei counterstained with DAPI (blue).
Control : PBS only
- IP
Lab
Immunoprecipitation - Anti-KIF5B+KIF5C antibody [EPR10276(B)] (AB167429)
ab167429 (purified) at 1 : 20 dilution (2μg) immunoprecipitating KIF5B in HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate.
Lane 1 (input) : HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate 10μg
Lane 2 (+) : ab167429 & HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab167429 in HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate
For western blotting, VeriBlot for IP Detection Reagent (HRP) (ab131366) was used for detection at 1 : 1000 dilution.
Blocking and diluting buffer : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-KIF5B+KIF5C antibody [EPR10276(B)] (ab167429)
Predicted band size: 110 kDa
false
- WB
Lab
Western blot - Anti-KIF5B+KIF5C antibody [EPR10276(B)] (AB167429)
Blocking and diluting buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-KIF5B+KIF5C antibody [EPR10276(B)] (ab167429) at 1/5000 dilution
Lane 1:
Jurkat (human acute T cell leukemia) whole cell lysates at 20 µg
Lane 2:
HeLa (Human cervix adenocarcinoma epithelial cell ) whole cell lysates at 20 µg
Lane 3:
Mouse brain lysates at 20 µg
Lane 4:
Rat brain lysates at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 110 kDa
false
- WB
Supplier Data
Western blot - Anti-KIF5B+KIF5C antibody [EPR10276(B)] (AB167429)
Lane 1 : Wild-type HAP1 whole cell lysate (20 μg)
Lane 2 : KIF5B knockout HAP1 whole cell lysate (20 μg)
Lanes 1 - 2 : Merged signal (red and green). Green - ab167429 observed at 110 kDa. Red - loading control, ab9484, observed at 37 kDa.
Unpurified ab167429 was shown to specifically react with KIF5B in wild-type cells as signal was lost in KIF5B knockout cells. Wild-type and KIF5B knockout samples were subjected to SDS-PAGE. ab167429 and ab9484 (Mouse anti-GAPDH loading control) were incubated overnight at 4°C at 1/1000 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-KIF5B+KIF5C antibody [EPR10276(B)] (ab167429)
Predicted band size: 110 kDa
false
- WB
Unknown
Western blot - Anti-KIF5B+KIF5C antibody [EPR10276(B)] (AB167429)
All lanes:
Western blot - Anti-KIF5B+KIF5C antibody [EPR10276(B)] (ab167429) at 1/1000 dilution
Lane 1:
Human fetal kidney lysate at 10 µg
Lane 2:
HeLa lysate at 10 µg
Lane 3:
Jurkat lysate at 10 µg
Lane 4:
HepG2 lysate at 10 µg
Secondary
All lanes:
Goat anti-rabbit HRP at 1/2000 dilution
Predicted band size: 110 kDa
false
- WB
Lab
Western blot - Anti-KIF5B+KIF5C antibody [EPR10276(B)] (AB167429)
Blocking and diluting buffer and concentration : 5% NFDM/TBST
ab181602 was used a GAPDH loading control.
All lanes:
Western blot - Anti-KIF5B+KIF5C antibody [EPR10276(B)] (ab167429) at 1/1000 dilution
Lane 1:
293T (Human embryonic kidney epithelial cell) +OE-empty at 20 µg
Lane 2:
293T (Human embryonic kidney epithelial cell) +OE-mouse KIF5A at 20 µg
Lane 3:
293T (Human embryonic kidney epithelial cell) +OE-mouse KIF5C at 20 µg
Lane 4:
293T (Human embryonic kidney epithelial cell) +OE-mouse KIF5B at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 110 kDa
false
Exposure time: 1s
Related conjugates and formulations (2)
-
Anti-KIF5B+KIF5C antibody [EPR10276(B)] - BSA and Azide free
-
578 PE
PE Anti-KIF5B+KIF5C antibody [EPR10276(B)]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Publications (54)
Recent publications for all applications. Explore the full list and refine your search
Nature cardiovascular research 4:1501-1520 PubMed41073815
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:3375 PubMed40204688
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 15:6891 PubMed40011606
2025
Applications
Unspecified application
Species
Unspecified reactive species
Neurospine 21:878-889 PubMed39363468
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 15:4740 PubMed38834545
2024
Applications
Unspecified application
Species
Unspecified reactive species
Proceedings of the National Academy of Sciences of the United States of America 121:e2401341121 PubMed38696466
2024
Applications
Unspecified application
Species
Unspecified reactive species
Military Medical Research 11:17 PubMed38475827
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell 187:276-293.e23 PubMed38171360
2024
Applications
Unspecified application
Species
Unspecified reactive species
CNS neuroscience & therapeutics 30:e14439 PubMed37641882
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 11:981425 PubMed37484914
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com